"Atherosclerosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA.
Descriptor ID |
D050197
|
MeSH Number(s) |
C14.907.137.126.307
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Atherosclerosis".
Below are MeSH descriptors whose meaning is more specific than "Atherosclerosis".
This graph shows the total number of publications written about "Atherosclerosis" by people in this website by year, and whether "Atherosclerosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 3 | 0 | 3 |
2006 | 2 | 3 | 5 |
2007 | 4 | 1 | 5 |
2008 | 7 | 1 | 8 |
2009 | 4 | 5 | 9 |
2010 | 5 | 3 | 8 |
2011 | 2 | 1 | 3 |
2012 | 5 | 0 | 5 |
2013 | 4 | 0 | 4 |
2014 | 3 | 1 | 4 |
2015 | 4 | 0 | 4 |
2016 | 8 | 5 | 13 |
2017 | 132 | 26 | 158 |
2018 | 131 | 29 | 160 |
2019 | 42 | 16 | 58 |
2020 | 6 | 1 | 7 |
2021 | 5 | 1 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Atherosclerosis" by people in Profiles.
-
Low-Dose Colchicine for the Management of Coronary Artery Disease. J Am Coll Cardiol. 2021 08 31; 78(9):867-869.
-
The impact of atherosclerotic cardiovascular disease, dyslipidaemia and lipid lowering therapy on Coronavirus disease 2019 outcomes: an examination of the available evidence. Curr Opin Lipidol. 2021 08 01; 32(4):231-243.
-
Cardiac pathology in COVID-19: a single center autopsy experience. Cardiovasc Pathol. 2021 Sep-Oct; 54:107370.
-
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies. Pharmacol Rev. 2021 07; 73(3):924-967.
-
Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives. Int J Mol Sci. 2021 Jun 21; 22(12).
-
Endothelial Cell Participation in Inflammatory Reaction. Int J Mol Sci. 2021 Jun 13; 22(12).
-
Extracellular Vesicles: Versatile Nanomediators, Potential Biomarkers and Therapeutic Agents in Atherosclerosis and COVID-19-Related Thrombosis. Int J Mol Sci. 2021 May 31; 22(11).
-
Cardiotoxicity of Immune Checkpoint Inhibitors. Curr Oncol Rep. 2021 05 03; 23(7):79.
-
Trace elements and the carotid plaque: the GOOD (Mg, Zn, Se), the UGLY (Fe, Cu), and the BAD (P, Ca)? Eur Rev Med Pharmacol Sci. 2021 05; 25(10):3772-3790.
-
Unraveling the molecular crosstalk between Atherosclerosis and COVID-19 comorbidity. Comput Biol Med. 2021 07; 134:104459.